J&J Gets FDA Approval of New Chemo-Free Lung Cancer Treatment

Key TakeawaysJohnson & Johnson made a pair of announcements Tuesday: Federal Drug Administration (FDA) approval of a new lung cancer treatment and an acquisition.The FDA approved a pair of drugs as a form of chemotherapy-free lung cancer treatment after a Phase 3 clinical trial showed the drugs reduce the risk of death or disease progression by 30% compared with the current standard of care.Johnson & Johnson also announced the $1.7 billion acquisition of privately-held V-Wave, expanding the company's offeri ...